Walmart's purpose — embodied by the company’s “save money, live better” value proposition — has become a more powerful force, motivating Walmart’s health-and-wellness strategies. And the retailer is much more broadly thinking about its potential role in an evolving healthcare delivery system, where cost promises to be the dominant consideration for decades to come and nutrition will play a great role.
Click below to download the full Walmart Annual Report.
DSN profiles the top 10 drug wholesalers.
Tens of billions of dollars have flooded into health IT in recent years, making that sector "as sexy an [investment] as social media and gaming," experts say. Find out what 15 leading pharmacy services companies — traditionalists and start-ups alike — are doing to bring new innovation to the HIT segment.
CVS Caremark has grown from a go-getting New England-based regional player to a nearly $100 billion pharmacy healthcare giant known for its vertically integrated pharmacy-PBM model via the 2007 acquisition of Caremark, its highly successful loyalty card program and its innovative beauty concepts. Now, the industry trailblazer embarks on a new chapter with a new leader and an eye on driving medication adherence, curbing healthcare costs and improving the health outcomes of its patients.
Behind every prescription that lands at the pharmacy counter is a series of events that influence the prescriber’s decision. Powered by data from SDI Health, Drug Store News goes inside the examination room in this exclusive report, providing an in-depth look at the critical factors that shape pharmaceutical sales trends and shift market share from one drug to another in 10 key market segments.
With its latest string of initiatives designed to bring it out of a slump that lasted more than a decade, Rite Aid is aiming for “wellness” to do for it what the lowercase “i” did for Apple.
Happy days are here again! Consumer confidence rebounded 1.6 points in April from a dip in March, according to the Consumer Confidence Index, despite the fact that high-gas-price stories are dominating the airwaves. That suggests consumers may be willing to try new things again — in other words, to buy something new — and that is excellent news for niche manufacturers. In this annual report, DSN calculates the value of niche brands.
85% — that’s more or less the combined market share for the companies that make up the 2011 DSN PoweRx50, approximately $185 billion of the total $218 billion retail pharmacy industry. The DSN PoweRx50 indisputably reflects the true titans of the retail pharmacy industry. It is the ONLY truly CHANNEL-AGNOSTIC ranking of the retail pharmacy industry that measures all of retail pharmacy, including traditional drug chains, independents, supermarkets, mass and club stores — ALL of it. BA-BOOM!
In November 2010, The Drug Store News Group hosted in New York an exclusive round-table discussion among leading executives from a vast array of retailers and a handful of key vendors. Moderated by DSN editor-in-chief Rob Eder, the panel tackled a wide range of issues, from the role of private label to improving store execution, inventory optimization and more. In part two, featured here, the panel tackles beauty care.
There are a million stories in the retail pharmacy industry — this is about a dozen of them. Early in 2011, the editors and publishers of Drug Store News put out a call to select members of the vendor community for a chance to tell the stories of their companies, in their own words. What followed is DSN’s first-ever user-generated special report.